• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply
Sort by Relevance
CSV RIS
Search Results [15895 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2011 Institute for Clinical Effectiveness and Health Policy (IECS) [Robotic gynecological surgery]
2011 Institute for Clinical Effectiveness and Health Policy (IECS) [Real time intraoperative magnetic resonance imaging monitoring]
2011 Institute for Clinical Effectiveness and Health Policy (IECS) [Percutaneous acrylic vertebroplasty for the treatment of vertebral fractures]
2011 Institute for Clinical Effectiveness and Health Policy (IECS) [Dalfampridine (ampyra) in multiple sclerosis patients]
2011 Institute for Clinical Effectiveness and Health Policy (IECS) [Microdebrider in nose-throat surgeries]
2011 Institute for Clinical Effectiveness and Health Policy (IECS) [The coblation technique in tonsillectomy]
2011 Institute for Clinical Effectiveness and Health Policy (IECS) [Dabigatran and rivaroxaban as thrombophylaxis after major orthopedic surgery]
2011 Institute for Clinical Effectiveness and Health Policy (IECS) [Rational use of self-monitoring of blood glucose in type 1 diabetes]
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Functional Electric Stimulation (FES) for children with cerebral palsy: clinical effectiveness
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Blood glucose monitors and test strips: a review of the comparative clinical evidence and cost-effectiveness
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Umbilical cord clamp removal: a review of the clinical benefits and harms
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Non-stress testing for pregnant adults with diabetes
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Surgical dressing for patients undergoing hip or knee arthroplasty: clinical effectiveness and cost-effectiveness
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Auditory screening and hearing loss prevention: a review of the clinical evidence and guidelines
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Upper extremity deep vein thrombosis with peripherally inserted central catheters: a review of the guidelines
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Cardiac output monitors to assess patient resuscitation needs: a review of clinical effectiveness and cost-effectiveness
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Quality assessment of the Canadian attention deficit hyperactivity disorder resource alliance ADHD practice guidelines in adults with ADHD
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Comparative effectiveness of rosuvastatin versus other statins: a review of clinical effectiveness
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Facet joint injection as diagnostic and therapeutic tools for pain of the cervical and lumbar spine: a review of clinical and cost-effectiveness
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Management and patient safety of IVIG administration: a review of clinical practice guidelines
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Pediatric supraglottic airway devices: a review of clinical effectiveness
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Robotic surgery versus open-chest surgery for internal mammary artery harvesting and mitral valve surgery: clinical effectiveness
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Feeding tube verification procedures: optimal timing and guidelines
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Non-adherent versus traditional dressings for wound care: comparative effectiveness, safety, and guidelines
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Intravenous insulin infusions in labouring women: guidelines
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Use of fentanyl and continuous electronic fetal monitoring in labour and delivery: a review of clinical effectiveness, safety, and clinical practice guidelines
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Antiviral stockpiling strategies for pandemic influenza: a review of the clinical and cost-effectiveness
2011 Agency for Healthcare Research and Quality (AHRQ) Therapies for children with autism spectrum disorders.
2011 Agency for Healthcare Research and Quality (AHRQ) Oral diabetes medications for adults with type 2 diabetes: an update
2011 Adelaide Health Technology Assessment (AHTA) Brachytherapy for the treatment of prostate cancer
2011 Health Council of the Netherlands Gezondheidsraad (GR) Treating the effect of child abuse
2011 Health Council of the Netherlands Gezondheidsraad (GR) Guidelines for a healthy diet: the ecological perspective
2011 Medical Advisory Secretariat (MAS) Corneal collagen cross-linking using riboflavin and ultraviolet-A for corneal thinning disorders
2011 The Swedish Council on Health Technology Assessment (SBU) Treatment of hemophilia A and B and von willebrand disease
2011 The Swedish Council on Health Technology Assessment (SBU) Medical and psychological methods for preventing sexual offences against children
2011 The Swedish Council on Health Technology Assessment (SBU) Computed tomography for suspected coronary artery disease
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Long versus short acting drugs for attention deficit/hyperactivity disorder in children and adolescents: a review of the guidelines and recommendations
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Education classes for diabetes management: a review of the comparative clinical and cost-effectiveness
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Functional Electrical Stimulation (FES) for children with spinal cord injuries: a review of the clinical effectiveness and guidelines
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Glyburide, gliclazide or glimepiride in the elderly with type 2 diabetes: a review of the clinical effectiveness and safety
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Fluticasone furoate versus fluticasone propionate for seasonal allergic rhinitis: a review of the clinical and cost-effectiveness
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Antiplatelet agents for acute coronary syndrome: a review of the guidelines and recommendations
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Calibration of blood glucose monitors for diabetes: a review of the clinical evidence and guidelines
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Venous thromboembolism prophylaxis for major general surgery: a review of the clinical effectiveness and guidelines
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Amisulpride for adults with refractory schizophrenia: a review of the clinical effectiveness and safety
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) The association between obesity, aboriginal or indigenous people, indian or alaskan natives living in North America and residence in remote locations and severe outcomes with seasonal and pandemic influenza: a review of the clinical evidence
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Preoperative skin antiseptic preparations and application techniques for preventing surgical site infections: a systematic review of the clinical evidence and guidelines
2011 Medical Advisory Secretariat (MAS) Constraint induced movement therapy for rehabilitation of arm dysfunction after stroke in adults
2011 Basque Office for Health Technology Assessment (OSTEBA) [Proposed health survey of the Basque Country for institutionalised population in nursing homes (ESCAV-IR). CAPV 2010]
2011 Norwegian Knowledge Centre for the Health Services (NOKC) [Treatment of chronic fatigue syndrome CFS/ME]
2011 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Renal denervation in patients with essential hypertonia]
2011 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Reorientation of the Austrian parent-child preventive care programme. Part I: Epidemiology - incidence of risk factors and diseases in pregnancy and early childhood]
2011 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Reorientation of the Austrian parent-child preventive care programme. Part II: international policies, approaches and screening strategies to "normal" and "risk experiences" during pregnancy and early childhood to school entry]
2011 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Reorientation of the Austrian parent-child preventive care programme. Part III: Status quo of the financing and cost structures of parent-child services in Austria]
2011 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Reorientation of the Austrian parent-child preventive care programme. Part IV: synthesis of parts 1-3, recommendations]
2011 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Disinvestment. Overview of disinvestment experiences and challenges in selected countries
2011 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Eribulin (Halaven) as third- or late- line mono-therapy for advanced/metastatic breast cancer
2011 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Sacral nerve stimulation for fecal incontinence]
2011 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Percutaneuous left atrial appendage closure for the prevention of thrombo-embolic events in patients with atrial fibrillation]
2011 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Mechanical percutaneous transluminal cerebral clot retrieval in acute ischemic stroke]
2011 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Selective internal radiation therapy using yttrium-90 microspheres for the treatment of primary or metastatic liver malignancies
2011 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Percutaneous aortic valve replacement with a side note to hybrid operating rooms]
2011 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Anti-Vascular-Endothelial-Growth-Factor (anti-VEGF) for the treatment of diabetic macular edema
2011 Adelaide Health Technology Assessment (AHTA) Prevention, identification and management of foot complications in diabetes: technical report
2011 Norwegian Knowledge Centre for the Health Services (NOKC) Thromboprophylactic treatment with rivaroxaban or dabigatran compared with enoxaparin or dalteparin in patients undergoing elective hip- or knee replacement surgery
2011 NIHR Horizon Scanning Centre (NIHR HSC) VEGF trap-eye (Eylea) for macular oedema secondary to central retinal vein occlusion - first line
2011 NIHR Horizon Scanning Centre (NIHR HSC) Trabectedin (Yondelis) for advanced and/or metastatic translocation-related sarcomas - first line
2011 NIHR Horizon Scanning Centre (NIHR HSC) Olesoxime for amyotrophic lateral sclerosis - first line
2011 NIHR Horizon Scanning Centre (NIHR HSC) Adalimumab (Humira) for axial spondyloarthritis - second line
2011 NIHR Horizon Scanning Centre (NIHR HSC) Liraglutide (Victoza) in combination with basal insulin for type 2 diabetes
2011 NIHR Horizon Scanning Centre (NIHR HSC) Eslicarbazepine acetate (Zebinix) for partial onset seizures in epilepsy - monotherapy
2011 NIHR Horizon Scanning Centre (NIHR HSC) Dapagliflozin and metformin fixed-dose combination for type 2 diabetes
2011 NIHR Horizon Scanning Centre (NIHR HSC) Agomelatine (Valdoxan) for generalised anxiety disorder - first or second line
2011 NIHR Horizon Scanning Centre (NIHR HSC) Bortezomib (Velcade) for multiple myeloma within a transplant setting
2011 NIHR Horizon Scanning Centre (NIHR HSC) Canagliflozin for type 2 diabetes mellitus
2011 NIHR Horizon Scanning Centre (NIHR HSC) Everolimus (Afinitor) in combination with exemestane for oestrogen receptor-positive, HER2-negative locally advanced or metastatic breast cancer
2011 NIHR Horizon Scanning Centre (NIHR HSC) Everolimus (Votubia) for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis - first line or post surgery
2011 NIHR Horizon Scanning Centre (NIHR HSC) Girentuximab (Rencarex) for renal cell carcinoma
2011 NIHR Horizon Scanning Centre (NIHR HSC) Lapatinib (Tyverb) for early stage ErbB2 (HER2) over-expressing breast cancer - adjuvant treatment
2011 NIHR Horizon Scanning Centre (NIHR HSC) Lapatinib (Tyverb) for squamous cell carcinoma of the head and neck - adjuvant and maintenance therapy
2011 NIHR Horizon Scanning Centre (NIHR HSC) Nitazoxanide for influenza - first line
2011 NIHR Horizon Scanning Centre (NIHR HSC) Pazopanib (Votrient) for ovarian, fallopian or peritoneal cancer
2011 NIHR Horizon Scanning Centre (NIHR HSC) Perampanel for epilepsy - adjunctive
2011 NIHR Horizon Scanning Centre (NIHR HSC) Phentermine/topiramate (Qnexa) for weight loss and maintenance of weight loss
2011 NIHR Horizon Scanning Centre (NIHR HSC) Rivaroxaban (Xarelto) for acute coronary syndrome
2011 NIHR Horizon Scanning Centre (NIHR HSC) Safinamide for early stage Parkinson's disease - adjuvant therapy
2011 NIHR Horizon Scanning Centre (NIHR HSC) Safinamide for mid-to-late stage Parkinson's disease - adjuvant therapy
2011 NIHR Horizon Scanning Centre (NIHR HSC) Sipuleucel-T (Provenge) for metastatic castration resistant prostate cancer - first line
2011 NIHR Horizon Scanning Centre (NIHR HSC) Strontium ranelate (Protelos) for osteoarthritis
2011 NIHR Horizon Scanning Centre (NIHR HSC) Zonisamide (Zonegran) for newly diagnosed partial seizures in epilepsy
2011 NIHR Horizon Scanning Centre (NIHR HSC) LAS 41005 (Actikeral) for actinic keratosis - first line
2011 NIHR Horizon Scanning Centre (NIHR HSC) Romidepsin (Istodax) for peripheral T-cell lymphoma, relapsed and/or refractory - second line
2011 NIHR Horizon Scanning Centre (NIHR HSC) Tivozanib for renal cell cancer, locally advanced or metastatic - first line
2011 NIHR Horizon Scanning Centre (NIHR HSC) Trastuzumab-DM1 (Herceptin-DM1) for breast cancer, locally advanced or metastatic, HER2 positive - second or third line
2011 NIHR Horizon Scanning Centre (NIHR HSC) Trastuzumab SC (Herceptin SC) for breast cancer, early or metastatic, HER2 positive - monotherapy or combination therapy, including neo-adjuvant and adjuvant use
2011 NIHR Horizon Scanning Centre (NIHR HSC) Mipomersen for familial hypercholesterolemia - third or fourth line
2011 NIHR Horizon Scanning Centre (NIHR HSC) Bromocriptine, quick release (Syncroset) for type 2 diabetes mellitus
2011 NIHR Horizon Scanning Centre (NIHR HSC) Brentuximab vedotin for systemic anaplastic large cell lymphoma relapsed and/or refractory - first line
2011 NIHR Horizon Scanning Centre (NIHR HSC) Brentuximab vedotin for Hodgkin's lymphoma, relapsing or remitting - first line
2011 NIHR Horizon Scanning Centre (NIHR HSC) Zibotentan in combination with docetaxel for prostate cancer, metastatic, castration resistant - in combination with docetaxel